Rare Diseases Coverage
Inflammatory Immune Cells Found in Active, But Not Chronic, Brain Lesions
NfL Promising Biomarker for Predicting Tecfidera Response
Vitamin D Binding Protein a Potential Biomarker in MS
Combining Different Tests Gives Clearer View of Patient Life Quality
Mindfulness Helps to Reduce Depression, Fatigue in MS Patients
Switching From Gilenya to Lemtrada May Not Be Optimal Choice, Study Says
Survey: COVID-19 Concerns Affected MS Management
Nerve Cell Loss in Retina Found to be Worse in Patients on Interferon-beta
TH17-suppressing Pregnancy Proteins May Be MS Therapeutic Target
2021 Innovation Challenge Finalists Announced
PPMS Patients ‘Drove’ Slowing in Brain Atrophy Seen With Ibudilast
Obesity, High BMI Linked to Greater MS Risk, Autoimmune Activity
Stem Cell Therapy Shows 2-year Benefit for Progressive MS Patients in Phase 1 Trial
Tecfidera Found in Breast Milk But Levels Appear Safe, Case Study Reports
Disease Progression Differs More Across MS Type Than Sex of Patients, Study Finds
Claire’s Place Expands COVID-19 Emergency Fund, Work Proudly Program
Top 10 Cystic Fibrosis Stories of 2020
Small Study Shows Tobramycin Safely Treats Lung Infection in Infants With CF
CF Foundation Hosts COVID-19 Vaccine Panel Talk, Q&A on Thursday
CF Patients and Families Favoring Telehealth as Option for Care, Survey Finds
Pilot Study Uses CRP, Calprotectin to Diagnose Pulmonary Exacerbations
Enrollment Complete in Phase 2 Trial Testing MS1819-PERT Combo for EPI
OPTION 2 Trial Testing MS1819 for EPI Posts ‘Mixed’ Topline Results
KB407 In-human Trial Expected After Gene Therapy Found Safe in Animals
Resistance Training Favorably Affects Youngsters’ Heart Rate
Real-world Study Review: Kalydeco Improves Health Outcomes, Quality of Life
Race, Income Limit CF Lung Transplant Access in US More Than Canada